Disparities in the Diagnosis and Treatment of Bile Duct Cancer in People with Disabilities: A National Cohort Study in South Korea.
Seon Mee ParkSo Young KimKyoung Eun YeobDong Wook ShinJoung-Ho HanJong Heon ParkJong Hyock ParkPublished in: International journal of environmental research and public health (2022)
We aimed to evaluate the impacts of disability on the diagnosis, treatment, and prognosis of bile duct cancer (BDC) according to the severity and type of disability. Patients diagnosed with BDC were selected from an age- and sex-matched population (1:3 ratio) with or without disabilities from the National Disability Database, the Korean Central Cancer Registry, and the Korean National Health Insurance claims database. The cohort included 15,065 patients with BDC, with a significantly lower rate in those with severe disabilities than in people without or with mild disabilities (110.6 vs. 136.5 vs. 147.6 per 105 persons, respectively). People with severe disabilities were diagnosed with BDC at an earlier age but were less likely to undergo surgery (adjusted odds ratio (aOR) = 0.52, 95% confidence interval (CI): 0.45-0.61) or chemotherapy (aOR = 0.76, 95% CI: 0.61-0.95) compared to those without disabilities. This trend was more evident in patients with mental disabilities. The overall and cancer-specific mortality rates were higher in patients (especially women) with disabilities than in those without. There needs systemic approach to ensure equal access to quality cancer care for people with disabilities.
Keyphrases
- papillary thyroid
- health insurance
- end stage renal disease
- multiple sclerosis
- squamous cell
- ejection fraction
- newly diagnosed
- quality improvement
- chronic kidney disease
- prognostic factors
- emergency department
- healthcare
- early onset
- cardiovascular disease
- radiation therapy
- coronary artery disease
- squamous cell carcinoma
- patient reported outcomes
- young adults
- adverse drug
- drug induced
- coronary artery bypass
- atrial fibrillation